Caerus Investment Advisors, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1862682
WEST LAKE HILLS, TX
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$254,326
-$78,449 QoQ
Shares Held
1,509
-40.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#561
of 768 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caerus Investment Advisors, LLC holds $497,607 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (51.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,509 | $254,326 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
449 | $243,281 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $254,326 | 1,509 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $332,775 | 2,526 | Shares | Sole | 2026-06-01 | |
| 2025-12-31 | $744,891 | 5,252 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $664,418 | 4,733 | Shares | Sole | 2025-11-20 | |
| No filing history on record for this holder in this stock. | ||||||